Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Colorectal Neoplasms × sintilimab × Clear all

Phase

Status

Sponsor Class

OTHER 17 UNKNOWN 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Neoplasm Metastasis 1 Head and Neck Squamous Cell Cancer 1 HER2-positive 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Capecitabine 4 Oxaliplatin 3 Fluorouracil 3 Bevacizumab 3 Radiosurgery 2 Leucovorin 2 Irinotecan 2 HMPL-013 2 toripalimab 1 sintilimab 1 endostar protein 1 Endostatins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04695470 2021-01-07

Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients

ChineseAMS

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡